CHINA SINOPHARM INTERNATIONAL CORPORATION

China National Pharmaceutical Group Co., Ltd. (Sinopharm) is a large state-owned healthcare group, with a full chain in the industry, ranking the 169th in Fortune Global 500 and the 6th pharmaceutical company in Fortune Global 500 in the year 2019.
China Sinopharm International Corporation (Sinopharm International) is the wholly-owned subsidiary of Sinopharm. The company shoulders Sinopharm’s strategic mission of developing international pharmaceutical business, and medical and healthcare industry. The main business covers international pharmaceutical trade, overseas pharmaceutical investment, international medical cooperation, and medical and health services.
With the help of the industry-wide advantages and strong supply capacity, Sinopharm has exported a large number of Personal Protective Equipment (PPE) to more than 120 countries (both government and commercial customers) so far including but not limited to 100 million pieces of Face Mask and Coverall etc., Electronic Equipment such as Ventilator and Patient Monitor, also PCR test reagent, Rapid Test and other IVD products. In addition, in the development of inactivated vaccines, SINOPHARM has completed the isolation and identification of the virus, the Phase III Clincal Trail of the vaccine has started in June.